The Discovery IQ Gen 2 builds upon its predecessor with enhanced digital detector performance, superior motion-correction technology (MotionFree), and advanced quantitation tools. It delivers high system sensitivity and a scalable axial field of view for improved small-lesion detectability, while maintaining efficient workflow and lower radiation dose. Engineered for clinical settings that demand speed, precision, and adaptability, it supports oncology, cardiology, neurology, and hybrid applications with confidence.
High NEMA sensitivity
High clinical NECR
Enhanced patient care
Motion correction & quantitation accuracy
